| 12/9/2021 |
CANbridge Signs Collaboration Agreement with the Peking Union Medical College on Rare Disease Research | Business Wire |
Business Wire |
... Mass.--( BUSINESS WIRE )--CANbridge Pharmaceuticals, Inc., a leading China-based global rare disease-focused biopharmaceutical company committed to the research, development and commercialization of transformative therapies, announced that it signed the collaboration on a rare disease research agreement with the Peking Union Medical College Hospital (PUMCH), on December 9, 2021. Under terms of the agreement, the two parties will collaborate on research and development in rare disease drug innovation, translational ... |
| 12/9/2021 |
CANbridge Signs Collaboration Agreement with the Peking Union Medical College on Rare Disease Research |
Business Wire |
... Dec 9, 2021--CANbridge Pharmaceuticals, Inc., a leading China-based global rare disease-focused biopharmaceutical company committed to the research, development and commercialization of transformative therapies, announced that it signed the collaboration on a rare disease research agreement with the Peking Union Medical College Hospital (PUMCH), on December 9, 2021. Under terms of the agreement, the two parties will collaborate on research and development in rare disease drug innovation, translational ... |
| 9/22/2021 |
Uplifting Athletes Tackles Funding for Rare Disease Research, Awareness |
pompediseasenews.com |
Uplifting Athletes Tackles Funding for Rare Disease Research, Awareness Football and science seem to be disparate fields of play at first glance, but the nonprofit Uplifting Athletes is finding common ground by leveraging the popularity of college gridiron games to fund research for rare diseases. Its nearly two dozen chapters — representing college football teams across the nation — are organizing fundraisers to help young researchers find treatments for the ... |
| 9/22/2021 |
Uplifting Athletes Tackles Funding for Rare Disease Research, Awareness |
rettsyndromenews.com |
Uplifting Athletes Tackles Funding for Rare Disease Research, Awareness Football and science seem to be disparate fields of play at first glance, but the nonprofit Uplifting Athletes is finding common ground by leveraging the popularity of college gridiron games to fund research for rare diseases. Its nearly two dozen chapters — representing college football teams across the nation — are organizing fundraisers to help young researchers find treatments for the ... |
| 9/16/2021 |
Drug makers failed to block House provision on orphan drug tax credits |
newsbinding.com |
WASHINGTON — Drug makers mounted a last-minute, and so far unsuccessful, campaign to kill a surprise provision in House Democrats’ massive spending package that will substantially curtail tax breaks meant to fuel rare disease research , according to an internal industry email obtained by STAT. The provision, which Democrats included in the spending package on Monday, cracks down on the so-called orphan drug tax credit. Currently, drug makers ... |
| 8/25/2021 |
Morning Headlines 8/25/21 |
HISTalk |
... Raises $20 Million of Growth Equity from Heritage Group Acute care telehealth and teleICU service provider Equum Medical raises $20 million in growth equity. AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research AllStripes, which offers real-world and patient data to support rare disease research , raises $50 million in a Series B funding round ... |
| 8/24/2021 |
AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research |
Yahoo News |
Lux Capital Led Funding, Joined by JAZZ Venture PartnersFinancing to Advance AllStripes’ Capabilities and Launch New Rare Disease Research ProgramsSAN FRANCISCO, August 24, 2021 --( BUSINESS WIRE )-- AllStripes ("Company"), a healthcare technology company dedicated to unlocking treatments for people affected by rare diseases, today announced the Company completed a $50 million Series B financing round.This press release features multimedia. View the full release here: https://www.businesswire.com/news ... |
| 8/24/2021 |
MBN Media |
mbn.media |
... Dassault Systemes company), McKesson Ventures, and Maveron, along with angel investors including Arif Nathoo, CEO of Komodo Health, and Leila Zegna, Director of the Kabuki Syndrome Foundation. The funding will support launching 100 new rare disease research programs while expanding global operational footprint, technology and data automation enhancements to improve research insights, further developing the platform capabilities to enhance the user experience and strengthen the life sciences offerings, and continuing ... |
| 8/24/2021 |
AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research | Business Wire |
Business Wire |
... Systèmes company), McKesson Ventures, and Maveron, along with angel investors including Arif Nathoo, CEO of Komodo Health, and Leila Zegna, Director of the Kabuki Syndrome Foundation.The funding will support launching 100 new rare disease research programs while expanding global operational footprint, technology and data automation enhancements to improve research insights, further developing the platform capabilities to enhance the user experience and strengthen the life sciences offerings, and continuing ... |
| 8/24/2021 |
AllStripes Raises $50M in Series B Financing |
finsmes.com |
... Ventures, and Maveron, along with angel investors including Arif Nathoo, CEO of Komodo Health, and Leila Zegna, Director of the Kabuki Syndrome Foundation. The company intends to use the funds to: - launch 100 new rare disease research programs - expand global operational presence, technology and data automation enhancements to improve research insights, - develop the platform capabilities to enhance the user experience and strengthen the life sciences offerings, and - continue to invest ... |
| 8/24/2021 |
AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research |
Business Wire |
... Systèmes company), McKesson Ventures, and Maveron, along with angel investors including Arif Nathoo, CEO of Komodo Health, and Leila Zegna, Director of the Kabuki Syndrome Foundation. The funding will support launching 100 new rare disease research programs while expanding global operational footprint, technology and data automation enhancements to improve research insights, further developing the platform capabilities to enhance the user experience and strengthen the life sciences offerings, and continuing ... |
| 8/24/2021 |
AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research |
digitalmedianet.com |
AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research Lux Capital Led Funding, Joined by JAZZ Venture Partners Financing to Advance AllStripes’ Capabilities and Launch New Rare Disease Research Programs SAN FRANCISCO–(BUSINESS WIRE)– healthtech — AllStripes (“Company”), a healthcare technology company dedicated to unlocking treatments for people affected by rare diseases, today announced the Company completed a $50 million Series B ... |
| 8/24/2021 |
AllStripes Announces $ 50 Million Series B Funding to Advance Global Rare Disease Research |
bollyinside.com |
The funding will support launching 100 new rare disease research programs while expanding global operational footprint, technology and data automation enhancements to improve research insights, further developing the platform capabilities to enhance the user experience and strengthen the life sciences offerings, and continuing to invest in growing the company’s team to support creating the playbook for rare disease research. The financing was led by Lux Capital, a current investor ... |
| 8/24/2021 |
AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research |
digitalproducer.com |
AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research Lux Capital Led Funding, Joined by JAZZ Venture Partners Financing to Advance AllStripes’ Capabilities and Launch New Rare Disease Research Programs SAN FRANCISCO–(BUSINESS WIRE)– healthtech — AllStripes (“Company”), a healthcare technology company dedicated to unlocking treatments for people affected by rare diseases, today announced the Company completed a $50 million Series B ... |
| 8/24/2021 |
AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research |
tmcnet.com |
TMCnet News [August 24, 2021] AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research AllStripes ("Company"), a healthcare technology company dedicated to unlocking treatments for people affected by rare diseases, today announced the Company completed a $50 million Series B financing round. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210824005315/en/ Nancy Yu, AllStripes CEO and Co-founder (Photo ... |
| 8/24/2021 |
AllStripes Secures $50M to Advance Global Rare Disease Research PlatforM |
HIT Consultant |
... by CEO Nancy Yu and technology developer Onno Faber, following his diagnosis and journey with the rare disease neurofibromatosis type 2. AllStripes has developed a technology platform that generates regulatory-ready evidence to accelerate rare disease research and drug development, as well as a patient application that empowers patients and families to securely participate in treatment research online and benefit from their own medical data. – The funding will support ... |
| 8/24/2021 |
AllStripes Raises $50 Million to Advance Global Rare Disease Research |
globalgenes.org |
... Solutions, McKesson Ventures, Maveron, along with angel investors including Komodo Health CEO Arif Nathoo, and Kabuki Syndrome Foundation Director Leila Zegna. AllStripes has developed a technology platform that generates regulatory-ready evidence to accelerate rare disease research and drug development, as well as a patient application that empowers patients and families to securely participate in treatment research online and benefit from their own medical data. The company was founded by ... |
| 8/24/2021 |
AllStripes raises $50 million to support rare disease research - MedCity News |
MedCity News |
A startup that lets patients share their health records for rare disease research plans to expand its programs with an influx of funding.San Francisco-based AllStripes recently closed a $50 million series B round, led by Lux Capital. It plans to use the capital to launch 100 rare disease research programs, build on its technology and expand its operations to more countries.AllStripes was founded in 2017 by CEO ... |
| 8/24/2021 |
AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research | Financial Buzz |
financialbuzz.com |
... Systèmes company), McKesson Ventures, and Maveron, along with angel investors including Arif Nathoo, CEO of Komodo Health, and Leila Zegna, Director of the Kabuki Syndrome Foundation.The funding will support launching 100 new rare disease research programs while expanding global operational footprint, technology and data automation enhancements to improve research insights, further developing the platform capabilities to enhance the user experience and strengthen the life sciences offerings, and continuing ... |
| 8/24/2021 |
AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research |
vcaonline.com |
... and macOS versions. It has been published since 1998. (Updated JULY 2021) Learn More » or Buy Now » AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research Lux Capital Led Funding, Joined by JAZZ Venture Partners Financing to Advance AllStripes’ Capabilities and Launch New Rare Disease Research Programs SAN FRANCISCO, August 24, 2021-- AllStripes (“Company”), a healthcare technology ... |